Shoudeng Chen

11PUBLICATIONS
47CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMolecular targetsVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 30, 2026
Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor-Binding and Non-Canonical Assembly Sites.

|Feb 20, 2026
Engineered nanovesicles as a DC vaccine to enhance the antitumor efficacy of CAR-T cells against solid tumors.

Shaolong Ju, Tianchuan Zhu, Shoudeng Chen

|Aug 19, 2025
Structural basis of a human antibody targeting SARS-CoV-2 nucleocapsid protein dimerization domain and interfering with RNA-binding.

Shaojie Xue, Suhua He, Zhaoxia Huang

|Jan 02, 2025
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung.

Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen

|Jan 10, 2024
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47.

Chunliu Huang, Xuefei Wang, Yingzhao Wang

|Jul 10, 2023
Individual bat virome analysis reveals co-infection and spillover among bats and virus zoonotic potential.

Jing Wang, Yuan-Fei Pan, Li-Fen Yang

Pageof 2

Frequent Collaborators

2 joint publications

Ziliang Zhou

2 joint publications

Xi Huang

1 joint publications

Fei Xiao

1 joint publications

Liang Wang